Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Biological Therapy Industry: Market Research Reports, Statistics and Analysis

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 review

(Image: F. Takemoto)

Global Biological Therapy Industry

 

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

 

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

 

 

...
More »

You might be interested in: cell therapy, stem cell, cell culture, more »

» View Public Reports

1-10 of about 300 reports

U.S. Biological Therapy Business

  • Industry report
  • January 2013
  • 49 pages

... Advani et al. Bruton tyrosine kinase ibrutinib (pci-32765) has significant activity in patients with relapsed/refractory b-cell malignancies. Journal of clinical oncology (31): 88-94 byrd, ash 2012 ...

  • Industries: Biological Therapy
  • Countries: United States

Biological Therapy Sector in Europe

  • Industry report
  • May 2012
  • 24 pages

... Relevant to advanced therapies, including: - medical devices - tissue engineering, - gene therapy, - cell therapy, - biotechnology, - surgery, - pharmacovigilance, - risk management - ethics ...

  • Industries: Biological Therapy
  • Countries: Europe

The Japanese Biological Therapy Business : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 22 pages
  • Industries: Biological Therapy
  • Countries: Japan

Biological Therapy Market in The United Kingdom

  • Industry report
  • April 2012
  • 10 pages

... Cell depletion significantly reduced antibody production. Intracellular cytokine staining showed that t cells are a major source of ifn-h9253 and il-10. Recombinant ply and, to a lesser extent, recombinant cbp ...

  • Industries: Biological Therapy
  • Countries: United Kingdom

Biological Therapy Industry in Canada, The United States and The United Kingdom

  • Industry report
  • January 2012
  • 7 pages

... Secretion, even when added up to an hour after the addition of escherichia coli o111:b4 lps to the human macrophage/monocyte-like thp-1 cell line. In contrast, bac2a demonstrated no significant antiendotoxin ...

  • Industries: Biological Therapy
  • Countries: Canada, United States, United Kingdom

Biological Therapy Market in Brazil and The United States

  • Industry report
  • April 2012
  • 10 pages

... Imbalance between pro- and production of anti-inflammatory cytokines and has been explained based on the th1 Th2 dichotomy and regulatory t cell activity. Recently, we demonstrated that il-17 produced during ...

  • Industries: Biological Therapy
  • Countries: Brazil, United States

Biological Therapy in India and The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 30 pages

... It for phase iii clinical trials in india at 20 cancer centers. rnai based products will most likely be the first product to hit the market in the next 18-24 months with a high success rate and huge market ...

  • Industries: Biological Therapy
  • Countries: India, United States

Biological Therapy Market in The United States and China

  • Industry report
  • May 2012
  • 10 pages
  • by Corporation
  • Industries: Biological Therapy
  • Countries: United States, China

Biological Therapy Market in Australia

  • Industry report
  • June 2012
  • 12 pages

... To be replaced by freshly lab-grown new ones. As a relatively new concept, research still has a long way to go until its full capabilities are known But in the meantime, stem cell technology is being taken ...

  • Industries: Biological Therapy
  • Countries: Australia

Biological Therapy Sector in South Korea

  • Industry report
  • April 2012
  • 11 pages
  • by Corporation

... Is a human keratinocyte line that rele- ases abnormal level of chemokines, including tarc, mdc, rantes, vascular endothelial growth factor, and eotaxin when stimulated with tnf- And ifn- . When released from ...

  • Industries: Biological Therapy
  • Countries: South Korea
Search in Biological Therapy Industry (About 300 reports)

» Purchase Premium Reports (From $ 55 - $ 6 813)

About 400 reports
Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...

Analytical Tool - Cancer Therapeutic Antibodies

March 2014 $ 5 924

Global Stem Cell Umbilical Cord Blood (ucb) Market (sto ...

January 2014 $ 4 515

Immunotherapy In Oncology Drug Pipeline Update 2014

March 2014 $ 3 675

Immunotherapy In Oncology: Drug Pathway Analyzer 2014

March 2014 $ 3 675

Regenerative Medicine And Stem Cells Partnering Terms A ...

March 2014 $ 2 995

Androgen Receptor Signaling Pathway In Oncology Drug Pi ...

March 2014 $ 2 249

Notch Signaling Pathway In Oncology Drug Pipeline Updat ...

March 2014 $ 2 249

B Cell Receptor Signaling Pathway In Oncology Drug Pipe ...

March 2014 $ 2 249

» Read our Company Profiles

10 Companies

Cryo-Save Group N.V.

Netherlands

Air Methods Corp.

United States

Stl Television Ltd.

United Kingdom

StemCells Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.